Showing results (291-300 of 400) with videos related to

Sort By:
Pageof 40
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|September 10, 2010
Chronic Administration of Monosodium Glutamate under Chronic Variable Stress Impaired Hypothalamic-Pituitary-Adrenal Axis Function in RatsHee Jeong Seo, Hyang-Do Ham, Hyung Yong Jin, et al.
Thoracic Cancer|July 8, 2016
Pulmonary sclerosing pneumocytoma mimicking lung cancer: Case report and review of the literatureJung-Hwan Lim, Nuri Lee, Dae-Woong Choi, et al.
Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi|February 12, 2019
Health Indicators Related to Disease, Death, and ReproductionJeoungbin Choi, Moran Ki, Ho Jang Kwon, et al.
Plos One|February 4, 2021
Hypersensitivity reactions to multiple anti-tuberculosis drugsHong-Joon Shin, Jin-Sun Chang, Min-Suk Kim, et al.
Nano Letters|February 20, 2019
Epitaxial van der Waals Contacts between Transition-Metal Dichalcogenide Monolayer PolymorphsChang-Soo Lee, Seung Jae Oh, Hoseok Heo, et al.
Journal of Korean Medical Science|October 7, 2016
Public Awareness of Stroke and Its Predicting Factors in Korea: a National Public Telephone Survey, 2012 and 2014Gyung Jae Oh, Jiyoung Moon, Yu Mi Lee, et al.
Nature Communications|April 4, 2024
Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8<sup>+</sup> T cells in murine models of inflammationGil-Woo Lee, Young Ju Kim, Sung-Woo Lee, et al.
Thoracic Cancer|May 16, 2018
Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancerTae-Ok Kim, In-Jae Oh, Bo Gun Kho, et al.
BMC Cancer|August 28, 2016
Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trialIn-Jae Oh, Kyu-Sik Kim, Cheol-Kyu Park, et al.
Thoracic Cancer|November 4, 2016
Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment responseHa Young Park, Hyung Joo Oh, Ki-Hyun Kim, et al.
Pageof 40